Free Trial

The Clorox Company $CLX Position Reduced by United Services Automobile Association

Clorox logo with Consumer Staples background

Key Points

  • United Services Automobile Association significantly reduced its stake in The Clorox Company by 80.6% during the first quarter, leaving it with 7,076 shares valued at approximately $1,035,000.
  • Several institutional investors, including Meiji Yasuda Asset Management and Goldman Sachs, increased their stakes in Clorox, with Goldman Sachs raising its holdings by 147.6% to 707,005 shares.
  • Clorox recently announced a quarterly dividend increase to $1.24 per share, with a current dividend yield of 3.9%, reflecting a positive change from the previous quarter's dividend.
  • MarketBeat previews the top five stocks to own by October 1st.

United Services Automobile Association lowered its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 80.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 7,076 shares of the company's stock after selling 29,350 shares during the period. United Services Automobile Association's holdings in Clorox were worth $1,035,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its position in shares of Clorox by 0.4% during the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock worth $2,293,135,000 after acquiring an additional 65,924 shares during the last quarter. Northern Trust Corp grew its position in shares of Clorox by 2.3% during the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock worth $225,133,000 after acquiring an additional 34,655 shares during the last quarter. Invesco Ltd. grew its position in shares of Clorox by 7.4% during the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock worth $200,512,000 after acquiring an additional 94,371 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Clorox by 12.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,115,772 shares of the company's stock worth $181,213,000 after acquiring an additional 123,200 shares during the last quarter. Finally, Hsbc Holdings PLC grew its position in shares of Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock worth $159,699,000 after acquiring an additional 589,544 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Shares of NYSE:CLX traded down $0.66 during trading hours on Friday, hitting $123.75. 1,519,075 shares of the company's stock traded hands, compared to its average volume of 1,668,893. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company's fifty day simple moving average is $124.30 and its two-hundred day simple moving average is $132.67. The company has a market cap of $15.14 billion, a price-to-earnings ratio of 18.98, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same quarter last year, the firm posted $1.82 EPS. The business's revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were given a dividend of $1.24 per share. This is a positive change from Clorox's previous quarterly dividend of $1.22. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. Clorox's payout ratio is 76.07%.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.57% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CLX. Jefferies Financial Group decreased their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Wells Fargo & Company decreased their target price on shares of Clorox from $138.00 to $130.00 and set an "equal weight" rating for the company in a research report on Friday, September 5th. UBS Group decreased their target price on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Citigroup reiterated a "neutral" rating and issued a $135.00 target price (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Finally, Barclays decreased their target price on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Clorox presently has an average rating of "Reduce" and an average target price of $142.18.

Check Out Our Latest Analysis on CLX

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.